Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device

Exclusion Criteria

• •Subject who presents with ruptured aneurysm, unless rupture occured 30 days or more prior to screening.
• •Subject who presents with an intracranial mass or currently undergoing radiation therapy for carcinoma of the head or neck region.
• •Subject with an International Normalized Ratio (INR)≥ 1.5
• •Subject with serum creatinine level \>2mg/dl at time of enrollment
• •Subject with known allergies to nickel-titanium metal
• •Subject with known allergies to aspirin, heparin, ticlopidine, or clopidogrel
• •Subject with a life threatening allergy to contrast(unless treatment for allergy is tolerated)
• •Subject who has a known cardiac disorder, likely to be associated with cardioembolic symptoms such as atrial fibrillation
• •Subject with any condition which in the opinion of the treating physician would place the subject at a high risk of embolic stroke
• •Subject who is currently participating in another clinical research study
• •Subject who has had a previous intracranial stenting procedure associated with the target aneurysm
• •Subject who is unable to complete the required follow-up
• •Subject who is pregnant or breastfeeding
• •Subject who has participated in a drug study within the last 30 days